1. Home
  2. UOKA vs ALZN Comparison

UOKA vs ALZN Comparison

Compare UOKA & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UOKA
  • ALZN
  • Stock Information
  • Founded
  • UOKA 2002
  • ALZN 2016
  • Country
  • UOKA United Kingdom
  • ALZN United States
  • Employees
  • UOKA N/A
  • ALZN N/A
  • Industry
  • UOKA
  • ALZN Medicinal Chemicals and Botanical Products
  • Sector
  • UOKA
  • ALZN Health Care
  • Exchange
  • UOKA NYSE
  • ALZN Nasdaq
  • Market Cap
  • UOKA 2.7M
  • ALZN 2.3M
  • IPO Year
  • UOKA N/A
  • ALZN 2021
  • Fundamental
  • Price
  • UOKA $2.78
  • ALZN $2.77
  • Analyst Decision
  • UOKA
  • ALZN Strong Buy
  • Analyst Count
  • UOKA 0
  • ALZN 1
  • Target Price
  • UOKA N/A
  • ALZN $180.00
  • AVG Volume (30 Days)
  • UOKA 58.6K
  • ALZN 220.6K
  • Earning Date
  • UOKA 08-16-2025
  • ALZN 09-10-2025
  • Dividend Yield
  • UOKA N/A
  • ALZN N/A
  • EPS Growth
  • UOKA N/A
  • ALZN N/A
  • EPS
  • UOKA N/A
  • ALZN N/A
  • Revenue
  • UOKA $48,375.00
  • ALZN N/A
  • Revenue This Year
  • UOKA N/A
  • ALZN N/A
  • Revenue Next Year
  • UOKA N/A
  • ALZN N/A
  • P/E Ratio
  • UOKA N/A
  • ALZN N/A
  • Revenue Growth
  • UOKA N/A
  • ALZN N/A
  • 52 Week Low
  • UOKA $1.98
  • ALZN $2.63
  • 52 Week High
  • UOKA $42.50
  • ALZN $135.54
  • Technical
  • Relative Strength Index (RSI)
  • UOKA N/A
  • ALZN 35.91
  • Support Level
  • UOKA N/A
  • ALZN $2.92
  • Resistance Level
  • UOKA N/A
  • ALZN $3.60
  • Average True Range (ATR)
  • UOKA 0.00
  • ALZN 0.21
  • MACD
  • UOKA 0.00
  • ALZN -0.00
  • Stochastic Oscillator
  • UOKA 0.00
  • ALZN 15.31

About UOKA MDJM LTD

MDJM Ltd is engaged in providing real estate agency services to its real estate developer clients, and provides, on an as-needed basis, real estate consulting services and independent training services. The company generates all of its revenue from Hotel income. The company derives a majority of its revenue from the United Kingdom.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: